Abstract
Perfluorinated compounds such as the perfluoroalkyl acids (PFAAs) and their derivatives are important man-made chemicals that have wide consumer and industrial applications. They are relatively contemporary chemicals, being in use only since the 1950s and until recently have been considered as biologically inactive. However, during the past decade, their global distribution, environmental persistence, presence in humans and wildlife, and adverse health effects in laboratory animals have come to light, generating scientific, regulatory, and public interest on an international scale. This chapter will provide a brief overview of recent advances in understanding environmental and human exposure, toxicology, and modes of action for this class of compounds in animal models, as well as a summary of epidemiological findings to date.
The information in this document has been subjected to review by the Office of Pollution Prevention and Toxics and the Office of Research and Development of US Environmental Protection Agency and approved for publication. Approval does not signify that the contents reflect the views of the agency, nor does mention of trade names or commercial products constitute endorsement or recommendation for use.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
D’eon JC, Crozier PW, Furdui CI, Reiner EJ, Libelo EL, Mabury SA (2009) Perfluorinated phosphonic acids in Canadian surface waters and wastewater treatment plant effluent: discovery of a new class of perfluorinated acids. Environ Toxicol Chem 28:2101–2107
D’eon JC, Mabury SA (2010) Uptake and eliminated of perfluorinated phosphonic acids in the rat. Environ Toxicol Chem 29:1319–1329
Giesy JP, Kannan K (2001) Perfluorochemical surfactants in the environment. Environ Sci Technol 36:146A–152A
Kudo N, Kawashima Y (2003) Toxicity and toxicokinetics of perflurooctanoic acid in humans and animals. J Toxicol Sci 28:49–57
Kennedy GL, Butenhoff JL, Olsen GW, O’Connor JC, Seacat AM, Perkins RG, Biegel LB, Murphy SR, Farrar DG (2004) The toxicology of perfluorooctanoate. Crit Rev Toxicol 34:351–384
Lau C, Butenhoff JL, Rogers JM (2004) The developmental toxicity of perfluoroalkyl acids and their derivatives. Toxicol Appl Pharmacol 198:231–241
Houde M, Martin JW, Letcher RJ, Solomon KR, Muir DCG (2006) Biological monitoring of polyfluoroalkyl substances: a review. Environ Sci Technol 40:3463–3473
Beach SA, Newsted JL, Coady K, Giesy JP (2006) Ecotoxicological evaluation of perfluorooctanesulfonate (PFOS). Rev Environ Contam Toxicol 186:133–174
Lau C, Anitole K, Hodes C, Lai D, Pfahles-Hutchens A, Seed J (2007) Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci 99:366–394
Andersen ME, Butenhoff JL, Chang SC, Farrar DG, Kennedy GL, Lau C, Olsen GW, Seed J, Wallace KB (2008) Perfluoroalkyl acids and related chemistries – Toxicokinetics and modes of action. Toxicol Sci 102:3–14
Kovarova J, Svobodova Z (2008) Perfluorinated compounds: occurrence and risk profile. Neuroendocrinol Lett 29:599–608
Fromme H, Tittlemier SA, Völkel W, Wilhelm M, Twardella D (2009) Perfluorinated compounds – exposure assessment for the general population in Western countries. Int J Hyg Environ Health 212:239–270
Olsen GW, Butenhoff JL, Zobel LR (2009) Perfluoroalkyl chemicals and human fetal development: an epidemiologic review with clinical and toxicological perspectives. Reprod Toxicol 27:212–230
Steenland K, Fletcher T, Savitz DA (2010) Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA). Environ Health Perspect 118:1100–1108
Giesy JP, Naile JE, Khim JS, Jones PD, Newsted JL (2010) Aquatic toxicology of perfluorinated chemicals. Rev Environ Contam Toxicol 202:1–52
Lehmler HJ (2005) Synthesis of environmentally relevant fluorinated surfactants – a review. Chemosphere 58:1471–1496
Kissa E (2001) Fluorinated surfactants and repellants, 2nd edn. Marcel Decker, New York, NY
Vanden Heuvel JP, Sterchele PE, Nesbit DJ, Peterson RE (1993) Coordinate induction of acyl-CoA binding protein, fatty acid binding protein and peroxisomal β-oxidation by peroxisome proliferators. Biochim Biophys Acta 1177:183–190
Luebker DJ, Hansen KJ, Bass NM, Butenhoff JL, Seacat AM (2002) Interactions of fluorochemicals with rat liver fatty acid-binding protein. Toxicology 176:175–185
Woodcroft MW, Ellis DA, Rafferty SP, Burns DC, March RE, Stock NL, Trumpour KS, Yee J, Munro K (2010) Experimental characterization of the mechanism of perfluorocarboxylic acids’ liver protein bioaccumulation: the key role of the neutral species. Environ Toxicol Chem 29:1669–1677
Vanden Heuvel JP, Kuslikis BI, Peterson RE (1992) Covalent binding of perfluorinated fatty acids to proteins in the plasma, liver and testes of rats. Chem Biol Interact 82:317–328
Han X, Snow TA, Kemper RA, Jepson GW (2003) Binding of perfluorooctanoic acid to rat and human plasma proteins. Chem Res Toxicol 16:775–781
Han X, Hinderliter PM, Snow TA, Jepson GW (2004) Binding of perfluorooctanoic acid to rat liver-form and kidney-form α2u-globulins. Drug Chem Toxicol 27:341–360
Jones PD, Hu W, De Coen W, Newsted JL, Giesy JP (2003) Binding of perfluorinated fatty acids to serum proteins. Environ Toxicol Chem 22:2639–2649
Chen YM, Guo LH (2009) Fluorescence study on site-specific binding of perfluoroalkyl acids to human serum albumin. Arch Toxicol 83:255–261
Bischel HN, Macmanus-Spencer LA, Luthy RG (2010) Noncovalent interactions of long-chain perfluoroalkyl acids with serum albumin. Environ Sci Technol 44:5263–5269
Weaver YM, Ehresman DJ, Butenhoff JL, Hagenbuch B (2010) Roles of rat renal organic anion transporters in transporting perfluorinated carboxylates with different chain lengths. Toxicol Sci 113:305–314
Cheng X, Klaassen CD (2008) Critical role of PPARα in perfluorooctanoic acid- and perfluorodecanoic acid-induced downregulation of Oatp uptake transporters in mouse livers. Toxicol Sci 106:37–45
Ikeda T, Aiba K, Fukuda K, Tanaka M (1985) The induction of peroxisome proliferation in rat liver by perfluorinated fatty acids, metabolically inert derivatives of fatty acids. J Biochem 98:475–482
Pastoor TP, Lee KP, Perri MA, Gillies PJ (1987) Biochemical and morphological studies of ammonium perfluorooctanoate-induced hepatomegaly and peroxisome proliferation. Exp Mol Pathol 47:98–109
Goecke-Flora CM, Wyman JF, Jarnot BM, Reo NV (1995) Effect of the peroxisome proliferator perfluoro-n-decanoic acid on glucose transport in the isolated perfused rat liver. Chem Res Toxicol 8:77–81
Intrasuksri U, Rangwala SM, O’Brien M, Noonan DJ, Feller DR (1998) Mechanisms of peroxisome proliferation by perfluorooctanoic acid and endogenous fatty acids. Gen Pharmacol 31:187–197
Vanden Heuvel JP, Thompson JT, Frame SR, Gillies PJ (2006) Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptor-α, -β, and -γ, liver X receptor-β, and retinoid X receptor-α. Toxicol Sci 92:476–489
Takacs ML, Abbott BD (2007) Activation of mouse and human peroxisome proliferator-activated receptors (α, β/δ, γ) by perfluorooctanoic acid and perfluorooctane sulfonate. Toxicol Sci 95:108–117
Rosen MB, Lee JS, Ren H, Vallanat B, Liu J, Waalkes MP, Abbott BD, Lau C, Corton JC (2008) Toxicogenomic dissection of the perfluorooctanoic acid transcript profile in mouse liver: evidence for the involvement of nuclear receptors PPARα and CAR. Toxicol Sci 103:46–56
Rosen MB, Abbott BD, Wolf DC, Corton JC, Wood CR, Schmid JE, Das KP, Zehr RD, Blair ET, Lau C (2008) Gene profiling in the livers of wild-type and PPARα-null mice exposed to perfluorooctanoic acid. Toxicol Pathol 36:592–607
Cheng X, Klaassen CD (2008) Perfluorocarboxylic acids induce cytochrome P450 enzymes in mouse liver through activation of PPAR-α and CAR transcription factors. Toxicol Sci 106:29–36
Ren H, Vallanat B, Nelson DM, Yeung LW, Guruge KS, Lam PK, Lehman-McKeeman LD, Corton JC (2009) Evidence for the involvement of xenobiotic-responsive nuclear receptors in transcriptional effects upon perfluoroalkyl acid exposure in diverse species. Reprod Toxicol 27:266–277
Hu W, Jones PD, DeCoen W, King L, Fraker P, Newsted J, Giesy JP (2003) Alterations in cell membrane properties caused by perfluorinated compounds. Comp Biochem Physiol C Toxicol Pharmacol 135:77–88
Lehmler HJ, Xie W, Bothun GD, Bummer PM, Knutson BL (2006) Mixing of perfluorooctanesulfonic acid (PFOS) potassium salt with dipalmitoyl phosphatidylcholine (DPPC). Colloids Surf B Biointerfaces 51:25–29
Xie W, Kania-Korwel I, Bummer PM, Lehmler HJ (2007) Effect of potassium perfluorooctanesulfonate, perfluorooctanoate and octanesulfonate on the phase transition of dipalmitoylphosphatidylcholine (DPPC) bilayers. Biochim Biophys Acta 1768:1299–1308
Matyszewska D, Leitch J, Bilewicz R, Lipkowski J (2008) Polarization modulation infrared reflection-absorption spectroscopy studies of the influence of perfluorinated compounds on the properties of a model biological membrane. Langmuir 24:7408–7412
Kawamoto K, Nishikawa Y, Oami K, Jin Y, Sato I, Saito N, Tsuda S (2008) Effects of perfluorooctane sulfonate (PFOS) on swimming behavior and membrane potential of paramecium caudatum. J Toxicol Sci 33:155–161
Xie W, Ludewig G, Wang K, Lehmler HJ (2010) Model and cell membrane partitioning of perfluorooctanesulfonate is independent of the lipid chain length. Colloids Surf B Biointerfaces 76:128–136
Xie W, Bothun GD, Lehmler HJ (2010) Partitioning of perfluorooctanoate into phosphatidylcholine bilayers is chain length-independent. Chem Phys Lipids 163:300–308
Harada KH, Ishii TM, Takatsuka K, Koizumi A, Ohmori H (2006) Effects of perfluorooctane sulfonate on action potentials and currents in cultured rat cerebellar Purkinje cells. Biochem Biophys Res Commun 351:240–245
Matyszewska D, Leitch J, Bilewicz R, Lipkowski J (2008) Polarization modulation infrared reflection-absorption spectroscopy studies of the influence of perfluorinated compounds on the properties of a model biological membrane. Langmuir 24:7408–7412
Upham BL, Deocampo ND, Wurl B, Trosko JE (1998) Inhibition of gap junctional intercellular communication by perfluorinated fatty acids is dependent on the chain length of the fluorinated tail. Int J Cancer 78:491–495
Hu W, Jones PD, Upham BL, Trosko JE, Lau C, Giesy JP (2002) Inhibition of gap junctional intercellular communication by perfluorinated compounds in rat liver and dolphin kidney epithelial cell lines in vitro and Sprague–Dawley rats in vivo. Toxicol Sci 68:429–436
Upham BL, Park JS, Babica P, Sovadinova I, Rummel AM, Trosko JE, Hirose A, Hasegawa R, Kanno J, Sai K (2009) Structure-activity-dependent regulation of cell communication by perfluorinated fatty acids using in vivo and in vitro model systems. Environ Health Perspect 117:545–551
Berthiaume J, Wallace KB (2002) Perfluorooctanoate, perflourooctanesulfonate, and N-ethyl perfluorooctanesulfonamido ethanol; Peroxisome proliferation and mitochondrial biogenesis. Toxicol Lett 129:23–32
O’Brien TM, Wallace KB (2004) Mitochondrial permeability transition as the critical target of N-acetyl perfluorooctane sulfonamide toxicity in vitro. Toxicol Sci 82:333–340
Walters MW, Bjork JA, Wallace KB (2009) Perfluorooctanoic acid stimulated mitochondrial biogenesis and gene transcription in rats. Toxicology 264:10–15
Kleszczyński K, Stepnowski P, Składanowski AC (2009) Mechanism of cytotoxic action of perfluorinated acids II. Disruption of mitochondrial bioenergetics. Toxicol Appl Pharmacol 235:182–190
Gordon SC (2010) Toxicological evaluation of ammonium 4,8-dioxa-3H-perfluorononanoate, a new emulsifier to replace ammonium perfluorooctanoate in fluoropolymer manufacturing. Regul Toxicol Pharmacol 59:64–80
Paul AG, Jones KC, Sweetman AJ (2009) A first global production, emission, and environmental inventory for perfluorooctane sulfonate. Environ Sci Technol 43:386–392
Wang N, Szostek B, Buck RC, Folsom PW, Sulecki LM, Capka V, Berti WR, Gannon JT (2005) Fluorotelomer alcohol biodegradation-direct evidence that perfluorinated carbon chains breakdown. Environ Sci Technol 39:7516–7528
Wang N, Szostek B, Folsom PW, Sulecki LM, Capka V, Buck RC, Berti WR, Gannon JT (2005) Aerobic biotransformation of 14C-labeled 8-2 telomer B alcohol by activated sludge from a domestic sewage treatment plant. Environ Sci Technol 39:531–538
Wallington TJ, Hurley MD, Xia J, Wuebbles DJ, Sillman S, Ito A, Penner JE, Ellis DA, Martin J, Mabury SA, Nielsen OJ, Sulbaek Andersen MP (2006) Formation of C7F15COOH (PFOA) and other perfluorocarboxylic acids during the atmospheric oxidation of 8:2 fluorotelomer alcohol. Environ Sci Technol 40:924–930
Liu J, Lee LS, Nies LF, Nakatsu CH, Turco RF (2007) Biotransformation of 8:2 fluorotelomer alcohol in soil and by soil bacteria isolates. Environ Sci Technol 41:8024–8030
Wang N, Szostek B, Buck RC, Folsom PW, Sulecki LM, Gannon JT (2009) 8:2 fluorotelomer alcohol aerobic soil biodegradation: pathways, metabolites, and metabolite yields. Chemosphere 75:1089–1096
Arakaki A, Ishii Y, Tokuhisa T, Murata S, Sato K, Sonoi T, Tatsu H, Matsunaga T (2010) Microbial biodegradation of a novel fluorotelomer alcohol, 1H,1H,2H,2H,8H,8H-perfluorododecanol, yields short fluorinated acids. Appl Microbiol Biotechnol 88:1193–1203
Young CJ, Mabury SA (2010) Atmospheric perfluorinated acid precursors: chemistry, occurrence, and impacts. Rev Environ Contam Toxicol 208:1–109
Lee H, D’eon J, Mabury SA (2010) Biodegradation of polyfluoroalkyl phosphates as a source of perfluorinated acids to the environment. Environ Sci Technol 44:3305–3310
Busch J, Ahrens L, Sturm R, Ebinghaus R (2010) Polyfluoroalkyl compounds in landfill leachates. Environ Pollut 158:1467–1471
Washington JW, Yoo H, Ellington JJ, Jenkins TM, Libelo EL (2010) Concentrations, distribution, and persistence of perfluoroalkylates in sludge-applied soils near Decatur, Alabama, USA. Environ Sci Technol 44:8390–8396
Yoo H, Washington JW, Ellington JJ, Jenkins TM, Neill MP (2010) Concentrations, distribution, and persistence of fluorotelomer alcohols in sludge-applied soils near Decatur, Alabama, USA. Environ Sci Technol 44:8397–8402
Nabb DL, Szostek B, Himmelstein MW, Mawn MP, Gargas ML, Sweeney LM, Stadler JC, Buck RC, Fasano WJ (2007) In vitro metabolism of 8-2 fluorotelomer alcohol: interspecies comparisons and metabolic pathway refinement. Toxicol Sci 100:333–344
Fasano WJ, Sweeney LM, Mawn MP, Nabb DL, Szostek B, Buck RC, Gargas ML (2009) Kinetics of 8-2 fluorotelomer alcohol and its metabolites, and liver glutathione status following daily oral dosing for 45 days in male and female rats. Chem Biol Interact 180: 281–295
Liu J, Wang N, Szostek B, Buck RC, Panciroli PK, Folsom PW, Sulecki LM, Bellin CA (2010) 6-2 Fluorotelomer alcohol aerobic biodegradation in soil and mixed bacterial culture. Chemosphere 78:437–444
Myers AL, Mabury SA (2010) Fate of fluorotelomer acids in a soil-water microcosm. Environ Toxicol Chem 29:1689–1695
Stahl T, Heyn J, Thiele H, Hüther J, Failing K, Georgii S, Brunn H (2009) Carryover of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) from soil to plants. Arch Environ Contam Toxicol 57:289–298
Armitage JM, Schenker U, Scheringer M, Martin JW, Macleod M, Cousins IT (2009) Modeling the global fate and transport of perfluorooctane sulfonate (PFOS) and precursor compounds in relation to temporal trends in wildlife exposure. Environ Sci Technol 43:9274–9280
Stock NL, Furdui VI, Muir DC, Mabury SA (2007) Perfluoroalkyl contaminants in the Canadian Arctic: evidence of atmospheric transport and local contamination. Environ Sci Technol 41:3529–3536
Young CJ, Furdui VI, Franklin J, Koerner RM, Muir DC, Mabury SA (2007) Perfluorinated acids in Arctic snow: new evidence for atmospheric formation. Environ Sci Technol 41:3455–3461
Yarwood G, Kemball-Cook S, Keinath M, Waterland RL, Korzeniowski SH, Buck RC, Russell MH, Washburn ST (2007) High-resolution atmospheric modeling of fluorotelomer alcohols and perfluorocarboxylic acids in the North American troposphere. Environ Sci Technol 41:5756–5762
Kwok KY, Taniyasu S, Yeung LW, Murphy MB, Lam PK, Horii Y, Kannan K, Petrick G, Sinha RK, Yamashita N (2010) Flux of perfluorinated chemicals through wet deposition in Japan, the United States, and several other countries. Environ Sci Technol 44:7043–7049
Yamashita N, Kannan K, Taniyasu S, Horii Y, Petrick G, Gamo T (2005) A global survey of perfluorinated acids in oceans. Mar Pollut Bull 51:658–668
Yamashita N, Taniyasu S, Petrick G, Wei S, Gamo T, Lam PK, Kannan K (2008) Perfluorinated acids as novel chemical tracers of global circulation of ocean waters. Chemosphere 70:1247–1255
Busch J, Ahrens L, Xie Z, Sturm R, Ebinghaus R (2010) Polyfluoroalkyl compounds in the East Greenland Arctic Ocean. J Environ Monit 12:1242–1246
Ahrens L, Xie Z, Ebinghaus R (2010) Distribution of perfluoroalkyl compounds in seawater from northern Europe, Atlantic Ocean, and Southern Ocean. Chemosphere 78:1011–1016
Davis KL, Aucoin MD, Larsen BS, Kaiser MA, Hartten AS (2007) Transport of ammonium perfluorooctanoate in environmental media near a fluoropolymer manufacturing facility. Chemosphere 67:2011–2019
Harada K, Nakasanishi S, Sasaki K, Furuyama K, Nakayama S, Saito N, Yamakawa K, Koizumi A (2006) Particle size distribution and respiratory deposition estimates of airborne perfluorooctanoate and perfluooctanesulfonate in Kyoto area, Japan. Bull Environ Contam Toxicol 76:306–310
Barber JL, Berger U, Chaemfa C, Huber S, Jahnke A, Temme C, Jones KC (2007) Analysis of per- and polyfluorinated alkyl substances in air samples from Northwest Europe. J Environ Monit 9:530–541
Niisoe T, Harada KH, Ishikawa H, Koizumi A (2009) Long-term simulation of human exposure to atmospheric perfluorooctanoic acid (PFOA) and perfluorooctanoate (PFO) in the Osaka urban area, Japan. Environ Sci Technol 44:7852–7857
Langer V, Dreyer A, Ebinghaus R (2010) Polyfluorinated compounds in residential and nonresidential indoor air. Environ Sci Technol 44:8075–8081
Strynar MJ, Lindstrom AB (2008) Perfluorinated compounds in house dust from Ohio and North Carolina, USA. Environ Sci Technol 42:3751–3756
Kato K, Calafat AM, Needham LL (2009) Polyfluoroalkyl chemicals in house dust. Environ Res 109:518–523
Björklund JA, Thuresson K, De Wit CA (2009) Perfluoroalkyl compounds (PFCs) in indoor dust: concentrations, human exposure estimates, and sources. Environ Sci Technol 43:2276–2281
Wang Y, Fu J, Wang T, Liang Y, Pan Y, Cai Y, Jiang G (2010) Distribution of perfluorooctane sulfonate and other perfluorochemicals in the ambient environment around a manufacturing facility in China. Environ Sci Technol 44:8062–8067
Rumsby PC, McLaughlin CL, Hall T (2009) Perfluorooctane sulphonate and perfluorooctanoic acid in drinking and environmental waters. Philos Transact A Math Phys Eng Sci 367:4119–4136
Suja F, Pramanik BK, Zain SM (2009) Contamination, bioaccumulation and toxic effects of perfluorinated chemicals (PFCs) in the water environment: a review paper. Water Sci Technol 60:1533–1544
Mak YL, Taniyasu S, Yeung LW, Lu G, Jin L, Yang Y, Lam PK, Kannan K, Yamashita N (2009) Perfluorinated compounds in tap water from China and several other countries. Environ Sci Technol 43:4824–4829
Quiñones O, Snyder SA (2009) Occurrence of perfluoroalkyl carboxylates and sulfonates in drinking water utilities and related waters from the United States. Environ Sci Technol 43:9089–9095
Ericson I, Domingo JL, Nadal M, Bigas E, Llebaria X, van Bavel B, Lindström G (2009) Levels of perfluorinated chemicals in municipal drinking water from Catalonia, Spain: public health implications. Arch Environ Contam Toxicol 57:631–638
Jin YH, Liu W, Sato I, Nakayama SF, Sasaki K, Saito N, Tsuda S (2009) PFOS and PFOA in environmental and tap water in China. Chemosphere 77:605–611
Nakayama SF, Strynar MJ, Reiner JL, Delinsky AD, Lindstrom AB (2010) Determination of perfluorinated compounds in the upper Mississippi river basin. Environ Sci Technol 44:4103–4109
Paustenbach DJ, Panko JM, Scott PK, Unice KM (2007) A methodology for estimating human exposure to perfluorooctanoic acid (PFOA): a retrospective exposure assessment of a community (1951-2003). J Toxicol Environ Health A 70:28–57
Drinking Water Inspectorate (2007) Guidance on the water supply (water quality) regulation 2000–2001 specific to PFOS (perfluorooctane sulphonate) and PFOA (perfluorooctanoic acid) concentrations in drinking water
Drinking Water Commission, German Ministry of Health (2006) Provisional evaluation of PFT in drinking water with the guide substances perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) as examples. Online available at http://www.umweltbundesamt.de/uba-info-presse-e/hintergrund/pft-in-drinking-water.pdf
New Jersey health-based drinking water guidance for PFOA (2009). Online available at http://www.state.nj.us/dep/watersupply/pfoa.htm
Minnesota health-based drinking water guidance for perfluorinated chemicals (2009). Online available at http://www.health.state.mn.us/divs/eh/risk/guidance/gw/table.html
US Environmental Protection Agency (2009) Provisional health advisory for PFOA and PFOS in drinking water. Online available at http://water.epa.gov/action/advisories/drinking/upload/2009_01_15_criteria_drinking_pha-PFOA_PFOS.pdf
Wilhelm M, Kraft M, Rauchfuss K, Hölzer J (2008) Assessment and management of the first German case of a contamination with perfluorinated compounds (PFC) in the Region Sauerland, North Rhine-Westphalia. J Toxicol Environ Health A 71:725–733
Brede E, Wilhelm M, Göen T, Müller J, Rauchfuss K, Kraft M, Hölzer J (2010) Two-year follow-up biomonitoring pilot study of residents’ and controls’ PFC plasma levels after PFOA reduction in public water system in Arnsberg, Germany. Int J Hyg Environ Health 213:217–223
Renner R (2009) Are perfluorochemicals widespread in biosolids? Environ Sci Technol 43:5164
Clarke BO, Smith SR (2011) Review of ‘emerging’ organic contaminants in biosolids and assessment of international research priorities for the agricultural use of biosolids. Environ Int 37:226–247
Bossi R, Strand J, Sortkjaer O, Larsen MM (2007) Perfluoroalkyl compounds in Danish wastewater treatment plants and aquatic environments. Environ Int 34:443–450
Plumlee MH, Larabee J, Reinhard M (2008) Perfluorochemicals in water reuse. Chemosphere 72:1541–1547
Ahrens L, Felizeter S, Sturm R, Xie Z, Ebinghaus R (2009) Polyfluorinated compounds in waste water treatment plant effluents and surface waters along the River Elbe, Germany. Mar Pollut Bull 58:1326–1333
Yu J, Hu J, Tanaka S, Fujii S (2009) Perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) in sewage treatment plants. Water Res 43:2399–2408
Guo R, Sim WJ, Lee ES, Lee JH, Oh JE (2010) Evaluation of the fate of perfluoroalkyl compounds in wastewater treatment plants. Water Res 44:3476–3486
Kannan K, Koistinen J, Beckmen K, Evans T, Gorzelany JF, Hansen KJ, Jones PD, Helle E, Nyman M, Giesy JP (2001) Accumulation of perfluorooctane sulfonate in marine mammals. Environ Sci Technol 35:1593–1598
Giesy JP, Kannan K (2001) Global distribution of perfluorooctane sulfonate in wildlife. Environ Sci Technol 35:1339–1342
Giesy JP, Kannan K, Jones PD (2001) Global biomonitoring of perfluorinated organics. Sci World J 1:627–629
Löfstrand K, Jörundsdóttir H, Tomy G, Svavarsson J, Weihe P, Nygård T, Bergman K (2008) Spatial trends of polyfluorinated compounds in guillemot (Uria aalge) eggs from North-Western Europe. Chemosphere 72:1475–1480
Ahrens L, Siebert U, Ebinghaus R (2009) Temporal trends of polyfluoroalkyl compounds in harbor seals (Phoca vitulina) from the German Bight, 1999-2008. Chemosphere 76:151–518
Hart K, Gill VA, Kannan K (2009) Temporal trends (1992-2007) of perfluorinated chemicals in Northern Sea Otters (Enhydra lutris kenyoni) from South-Central Alaska. Arch Environ Contam Toxicol 56:607–614
Butt CM, Berger U, Bossi R, Tomy GT (2010) Levels and trends of poly- and perfluorinated compounds in the arctic environment. Sci Total Environ 408:2936–2965
Letcher RJ, Bustnes JO, Dietz R, Jenssen BM, Jørgensen EH, Sonne C, Verreault J, Vijayan MM, Gabrielsen GW (2010) Exposure and effects assessment of persistent organohalogen contaminants in arctic wildlife and fish. Sci Total Environ 408:2995–3043
Olsen GW, Gilliland FD, Burlew MM, Burris JM, Mandel JS, Mandel JH (1998) An epidemiologic investigation of reproductive hormones in men with occupational exposure to perfluorooctanoic acid. J Occup Environ Med 40:614–622
Olsen GW, Burris JM, Mandel JH, Zobel LR (1999) Serum perfluorooctane sulfonate and hepatic and lipid clinical chemistry tests in fluorochemical production employees. J Occup Environ Med 41:799–806
Olsen GW, Burris JM, Burlew MM, Mandel JH (2003) Epidemiologic assessment of worker serum perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations. J Occup Environ Med 45:260–270
Olsen GW, Church TR, Miller JP, Burris JM, Hansen KJ, Lundberg JK, Armitage JB, Herron RM, Medhdizadehkashi Z, Nobiletti JB, O’Neill EM, Mandel JH, Zobel LR (2003) Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors. Environ Health Perspect 111:1892–1901; erratum in: Environ Health Perspect 111:1900
Calafat AM, Kuklenyik Z, Caudill SP, Reidy JA, Needham LL (2006) Perfluorochemicals in pooled serum samples from United States residents in 2001 and 2002. Environ Sci Technol 40:2128–2134
Kato K, Calafat AM, Wong LY, Wanigatunga AA, Caudill SP, Needham LL (2009) Polyfluoroalkyl compounds in pooled sera from children participating in the National Health and Nutrition Examination Survey 2001-2002. Environ Sci Technol 43:2641–2647
Calafat AM, Wong LY, Kuklenyik Z, Reidy JA, Needham LL (2007) Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ Health Perspect 115:1596–1602
CDC NHANES Report of the 2005-2006 Survey (2010). Online available at http://www.cdc.gov/exposurereport/pdf/Update_Tables.pdf
Kärrman A, Mueller JF, van Bavel B, Harden F, Toms LM, Lindström G (2006) Levels of 12 perfluorinated chemicals in pooled Australian serum, collected 2002-2003, in relation to age, gender, and region. Environ Sci Technol 40:3742–3748
Harada K, Koizumi A, Saito N, Inoue K, Yoshinaga T, Date C, Fujii S, Hachiya N, Hirosawa I, Koda S, Kusaka Y, Murata K, Omae K, Shimbo S, Takenaka K, Takeshita T, Todoriki H, Wada Y, Watanabe T, Ikeda M (2007) Historical and geographical aspects of the increasing perfluorooctanoate and perfluorooctane sulfonate contamination in human serum in Japan. Chemosphere 66:293–301
Jin Y, Saito N, Harada KH, Inoue K, Koizumi A (2007) Historical trends in human serum levels of perfluorooctanoate and perfluorooctane sulfonate in Shenyang, China. Tohoku J Exp Med 212:63–70
Haug LS, Thomsen C, Becher G (2009) Time trends and the influence of age and gender on serum concentrations of perfluorinated compounds in archived human samples. Environ Sci Technol 43:2131–2136
Toms LM, Calafat AM, Kato K, Thompson J, Harden F, Hobson P, Sjödin A, Mueller JF (2009) Polyfluoroalkyl chemicals in pooled blood serum from infants, children, and adults in Australia. Environ Sci Technol 43:4194–4199
Ingelido AM, Marra V, Abballe A, Valentini S, Iacovella N, Barbieri P, Porpora MG, Domenico A, Felip ED (2010) Perfluorooctanesulfonate and perfluorooctanoic acid exposures of the Italian general population. Chemosphere 80:1125–1130
Rylander C, Sandanger TM, Frøyland L, Lund E (2010) Dietary patterns and plasma concentrations of perfluorinated compounds in 315 Norwegian women: the NOWAC Postgenome Study. Environ Sci Technol 44:5225–5232
Zhang T, Wu Q, Sun HW, Zhang XZ, Yun SH, Kannan K (2010) Perfluorinated compounds in whole blood samples from infants, children, and adults in China. Environ Sci Technol 44:4341–4347
Olsen GW, Mair DC, Church TR, Ellefson ME, Reagen WK, Boyd TM, Herron RM, Medhdizadehkashi Z, Nobiletti JB, Rios JA, Butenhoff JL, Zobel LR (2008) Decline in perfluorooctanesulfonate and other polyfluoroalkyl chemicals in American Red Cross adult blood donors, 2000-2006. Environ Sci Technol 42:4989–4995
Inoue K, Okada F, Ito R, Kato S, Sasaki S, Nakajima S, Uno A, Saijo Y, Sata F, Yoshimura Y, Kishi R, Nakazawa H (2004) Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a susceptible population during pregnancy. Environ Health Perspect 112: 1204–1207
Apelberg BJ, Witter FR, Herbstman JB, Calafat AM, Halden RU, Needham LL, Goldman LR (2007) Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth. Environ Health Perspect 115:1670–1676
Monroy R, Morrison K, Teo K, Atkinson S, Kubwabo C, Stewart B, Foster WG (2008) Serum levels of perfluoroalkyl compounds in human maternal and umbilical cord blood samples. Environ Res 108:56–62
So MK, Yamashita N, Taniyasu S, Jiang Q, Giesy JP, Chen K, Lam PK (2006) Health risks in infants associated with exposure to perfluorinated compounds in human breast milk from Zhoushan, China. Environ Sci Technol 40:2924–2929
Tao L, Ma J, Kunisue T, Libelo EL, Tanabe S, Kannan K (2008) Perfluorinated compounds in human breast milk from several Asian countries, and in infant formula and dairy milk from the United States. Environ Sci Technol 42:8597–8602
von Ehrenstein OS, Fenton SE, Kato K, Kuklenyik Z, Calafat AM, Hines EP (2009) Polyfluoroalkyl chemicals in the serum and milk of breastfeeding women. Reprod Toxicol 27:239–245
Sundström M, Ehresman DJ, Bignert A, Butenhoff JL, Olsen GW, Chang SC, Bergman A (2011) A temporal trend study (1972-2008) of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in pooled human milk samples from Stockholm, Sweden. Environ Int 37:178–183
Liu J, Li J, Zhao Y, Wang Y, Zhang L, Wu Y (2010) The occurrence of perfluorinated alkyl compounds in human milk from different regions of China. Environ Int 36:433–438
Fromme H, Mosch C, Morovitz M, Alba-Alejandre I, Boehmer S, Kiranoglu M, Faber F, Hannibal I, Genzel-Boroviczény O, Koletzko B, Völkel W (2010) Pre- and postnatal exposure to perfluorinated compounds (PFCs). Environ Sci Technol 44:7123–7129
Kim SK, Lee KT, Kang CS, Tao L, Kannan K, Kim KR, Kim CK, Lee JS, Park PS, Yoo YW, Ha JY, Shin YS, Lee JH (2011) Distribution of perfluorochemicals between sera and milk from the same mothers and implications for prenatal and postnatal exposures. Environ Pollut 159:169–174
Begley TH, White K, Honigfort P, Twaroski ML, Neches R, Walker RA (2005) Perfluorochemicals: potential sources of and migration from food packaging. Food Addit Contam 22:1023–1031
Tittlemier SA, Pepper K, Seymour C, Moisey J, Bronson R, Cao XL, Dabeka RW (2007) Dietary exposure of Canadians to perfluorinated carboxylates and perfluorooctane sulfonate via consumption of meat, fish, fast foods, and food items prepared in their packaging. J Agric Food Chem 55:3203–3210
Kärrman A, Harada KH, Inoue K, Takasuga T, Ohi E, Koizumi A (2009) Relationship between dietary exposure and serum perfluorochemical (PFC) levels―a case study. Environ Int 35:712–717
Haug LS, Thomsen C, Brantsaeter AL, Kvalem HE, Haugen M, Becher G, Alexander J, Meltzer HM, Knutsen HK (2010) Diet and particularly seafood are major sources of perfluorinated compounds in humans. Environ Int 36:772–778
Haug LS, Salihovic S, Jogsten IE, Thomsen C, van Bavel B, Lindström G, Becher G (2010) Levels in food and beverages and daily intake of perfluorinated compounds in Norway. Chemosphere 80:1137–1143
Vestergren R, Cousins IT (2009) Tracking the pathways of human exposure to perfluorocarboxylates. Environ Sci Technol 43:5565–5575
European Food Safety Authority (2008) Opinion of the Scientific Panel on Contaminants in the Food chain on Perfluorooctane sulfonate (PFOS), perfluorooctanoic acid (PFOA) and their salts. The EFSA Journal 653:1–131
Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment (2006) COT statement on the tolerable daily intake for perfluorooctanoic acid
Committee on Toxicity of Chemicals in Food, Consumer Products and The Environment (2006) COT statement on the tolerable daily intake for perfluorooctane sulfonate
German Federal Institute for Risk Assessment (2006) High levels of perfluorinated organic surfactants in fish are likely to be harmful to human health Statement No. 21/2006
Bartell SM, Calafat AM, Lyu C, Kato K, Ryan PB, Steenland K (2010) Rate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West Virginia. Environ Health Perspect 118:222–228
Johnson JD, Gibson SJ, Ober RE (1984) Cholestyramine-enhanced fecal elimination of carbon-14 in rats after administration of ammonium [14C]perfluorooctanoate or potassium [14C]perfluorooctanesulfonate. Fundam Appl Toxicol 4:972–976
Hanhijarvi H, Ylinen M, Haaranen T, Nevalainen T (1988) A proposed species difference in the renal excretion of perfluorooctanoic acid in the beagle dog and rat. In: Beynen AC, Solleveld HA (eds) New development in biosciences: their implications for laboratory animal sciences. Martinus Nijhoff Publishers, Dordrecht, The Netherlands, pp 409–412
Vanden Heuvel JP, Kuslikis BI, Van Ragelghem ML, Peterson RE (1991) Tissue distribution, metabolism, and elimination of perfluorooctanoic acid in male and female rats. J Biochem Toxicol 6:83–92
Kudo N, Katakura M, Sato Y, Kawashima Y (2002) Sex hormone-regulated renal transport of perfluorooctanoic acid. Chem Biol Interact 139:301–316
Ohmori K, Kudo N, Katayama K, Kawashima Y (2003) Comparison of the toxicokinetics between perfluorocarboxylic acids with different carbon chain length. Toxicology 184:135–140
Butenhoff JL, Kennedy GL Jr, Hinderliter PM, Lieder PH, Jung R, Hansen KJ, Gorman GS, Noker PE, Thomford PJ (2004) Pharmacokinetics of perfluorooctanoate in cynomolgus monkeys. Toxicol Sci 82:394–406
Harada K, Inoue K, Morikawa A, Yoshinaga T, Saito N, Koizumi A (2005) Renal clearance of perfluorooctane sulfonate and perfluorooctanoate in humans and their species-specific excretion. Environ Res 99:253–261
Hinderliter PM, Mylchreest E, Gannon SA, Butenhoff JL, Kennedy GL (2005) Perfluorooctanoate: placental and lactational transport pharmacokinetics in rats. Toxicology 211: 139–148
Hundley SG, Sarrif AM, Kennedy GL (2006) Absorption, distribution, and excretion of ammonium perfluorooctanoate (APFO) after oral administration to various species. Drug Chem Toxicol 29:137–145
Hinderliter PM, Han X, Kennedy GL, Butenhoff JL (2006) Age effect on perfluorooctanoate (PFOA) plasma concentration in post-weaning rats following oral gavage with ammonium perfluorooctanoate (APFO). Toxicology 225:195–203
Olsen GW, Burris JM, Ehresman DJ, Froehlich JW, Seacat AM, Butenhoff JL, Zobel LR (2007) Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect 115:1298–1305
Chang SC, Das K, Ehresman DJ, Ellefson ME, Gorman GS, Hart JA, Noker PE, Tan YM, Lieder PH, Lau C, Olsen GW, Butenhoff JL (2008) Comparative pharmacokinetics of perfluorobutyrate in rats, mice, monkeys, and humans and relevance to human exposure via drinking water. Toxicol Sci 104:40–53
Lou I, Wambaugh JF, Lau C, Hanson RG, Lindstrom AB, Strynar MJ, Zehr RD, Setzer RW, Barton HA (2009) Modeling single and repeated dose pharmacokinetics of PFOA in mice. Toxicol Sci 107:331–341
Olsen GW, Chang SC, Noker PE, Gorman GS, Ehresman DJ, Lieder PH, Butenhoff JL (2009) A comparison of the pharmacokinetics of perfluorobutanesulfonate (PFBS) in rats, monkeys, and humans. Toxicology 256:65–74
Chengelis CP, Kirkpatrick JB, Myers NR, Shinohara M, Stetson PL, Sved DW (2009) Comparison of the toxicokinetic behavior of perfluorohexanoic acid (PFHxA) and nonafluorobutane-1-sulfonic acid (PFBS) in cynomolgus monkeys and rats. Reprod Toxicol 27:400–406
Benskin JP, De Silva AO, Martin LJ, Arsenault G, McCrindle R, Riddell N, Mabury SA, Martin JW (2009) Disposition of perfluorinated acid isomers in Sprague–Dawley rats; part 1: single dose. Environ Toxicol Chem 28:542–554
Tatum-Gibbs K, Wambaugh J, Das KP, Zehr RD, Strynar MJ, Lindstrom AB, Delinsky A, Lau C (2011) Comparative pharmacokinetics of perfluorononanoic acid in rat and mouse. Toxicology 281:48–55
Kudo N, Suzuki E, Katakura M, Ohmori K, Noshiro R, Kawashima Y (2001) Comparison of the elimination between perfluorinated fatty acids with different carbon chain length in rats. Chem Biol Interact 134:203–216
Buist SC, Cherrington NJ, Klaassen CD (2003) Endocrine regulation of rat organic anion transporters. Drug Metab Dispos 31:559–564
Ljubojevic M, Balen D, Breljak D, Kusan M, Anzai N, Bahn A, Burckhardt G, Sabolic I (2007) Renal expression of organic anion transporter OAT2 in rats and mice is regulated by sex hormones. Am J Physiol Renal Physiol 292:F361–372
Sundstrom M, Chang SC, Noker PE, Gorman GS, Hart JA, Ehresman DJ, Bergman A, Butenhoff JL (2011) Comparative pharmacokinetics of perfluorohexaneuslfonate (PFHxS) in rats, mice, and monkeys. Repord Toxicol. Epub ahead
Buist SC, Klaassen CD (2004) Rat and mouse differences in gender-predominant expression of organic anion transporter (Oat1-3; Slc22a6-8) mRNA levels. Drug Metab Dispos 32: 620–625
Yang CH, Glover KP, Han X (2010) Characterization of cellular uptake of perfluorooctanoate via organic anion-transporting polypeptide 1A2, organic anion transporter 4, and urate transporter 1 for their potential roles in mediating human renal reabsorption of perfluorocarboxylates. Toxicol Sci 117:294–302
OECD (2002) Hazard assessment of perfluorooctane sulfonate (PFOS) and its salts. Online available at http://www.oecd.org/document/58/0,3343,en_2649_34375_2384378_1_1_1_37465,00.html
Fernández Freire P, Pérez Martin JM, Herrero O, Peropadre A, de la Peña E, Hazen MJ (2008) In vitro assessment of the cytotoxic and mutagenic potential of perfluorooctanoic acid. Toxicol In Vitro 22:1228–1233
Kim SC, Hong JT, Jang SJ, Kang WS, Yoo HS, Yun YP (1998) Formation of 8-oxodeoxyguanosine in liver DNA and hepatic injury by peroxisome proliferator clofibrate and perfluorodecanoic acid in rats. J Toxicol Sci 23:113–119
Loveless SE, Slezak B, Serex T, Lewis J, Mukerji P, O’Connor JC, Donner EM, Frame SR, Korzeniowski SH, Buck RC (2009) Toxicological evaluation of sodium perfluorohexanoate. Toxicology 264:32–44
Yao X, Zhong L (2005) Genotoxic risk and oxidative DNA damage in HepG2 cells exposed to perfluorooctanoic acid. Mutat Res 587:38–44
Eriksen KT, Raaschou-Nielsen O, Sørensen M, Roursgaard M, Loft S, Møller P (2010) Genotoxic potential of the perfluorinated chemicals PFOA, PFOS, PFBS, PFNA and PFHxA in human HepG2 cells. Mutat Res 700:39–43
U.S. Environmental Protection Agency (US EPA) (2005) Draft risk assessment of the potential human health effects associated with exposure to perfluorooctanoic acid and its salts. Online available at http://www.epa.gov/opptintr/pfoa/pubs/pfoarisk.html
Hardisty JF, Willson GA, Brown WR, McConnell EE, Frame SR, Gaylor DW, Kennedy GL, Butenhoff JL (2010) Pathology Working Group review and evaluation of proliferative lesions of mammary gland tissues in female rats fed ammonium perfluorooctanoate (APFO) in the diet for 2 years. Drug Chem Toxicol 33:131–137
Liu RC, Hurtt ME, Cook JC, Biegel LB (1996) Effect of the peroxisome proliferator, ammonium perfluorooctanoate (C8), on hepatic aromatase activity in adult male Crl:CD BR (CD) rats. Fundam Appl Toxicol 30:220–228
Biegel LB, Hurtt ME, Frame SR, O’Connor JC, Cook JC (2001) Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats. Toxicol Sci 60:44–55
Tilton SC, Orner GA, Benninghoff AD, Carpenter HM, Hendricks JD, Pereira CB, Williams DE (2008) Genomic profiling reveals an alternate mechanism for hepatic tumor promotion by perfluorooctanoic acid in rainbow trout. Environ Health Perspect 116: 1047–1055
van Rafelghem MJ, Mattie DR, Bruner RH, Andersen ME (1987) Pathological and hepatic ultrastructural effects of a single dose of perfluoro-n-decanoic acid in the rat, hamster, mouse, and guinea pig. Fundam Appl Toxicol 9:522–540
Kudo N, Suzuki-Nakajima E, Mitsumoto A, Kawashima Y (2006) Responses of the liver to perfluorinated fatty acids with different carbon chain length in male and female mice:in relation to induction of hepatomegaly, peroxisomal beta-oxidation and microsomal 1-acylglycerophosphocholine acyltransferase. Biol Pharm Bull 29:1952–1957
Ehresman DJ, Chang S, Bjork JA, Hart JA, Lieder PH, Wallace KB, Butenhoff JL (2007) Increased acyl CoA oxidase activity in rats after five consecutive daily doses of perfluorobutanesulfonate, perfluorohexanesulfonate, and perfluorooctanesulfonate. Toxicologist 96:179
Lieder PH, York RG, Hakes DC, Chang SC, Butenhoff JL (2009) A two-generation oral gavage reproduction study with potassium perfluorobutanesulfonate (K+PFBS) in Sprague Dawley rats. Toxicology 259:33–45
Foreman JE, Chang SC, Ehresman DJ, Butenhoff JL, Anderson CR, Palkar PS, Kang BH, Gonzalez FJ, Peters JM (2009) Differential hepatic effects of perfluorobutyrate mediated by mouse and human PPAR-α. Toxicol Sci 110:204–211
Chengelis CP, Kirkpatrick JB, Radovsky A, Shinohara M (2009) A 90-day repeated dose oral (gavage) toxicity study of perfluorohexanoic acid (PFHxA) in rats (with functional observational battery and motor activity determinations). Reprod Toxicol 27:342–351
Kudo N, Bandai N, Suzuki E, Katakura M, Kawashima Y (2000) Induction by perfluorinated fatty acids with different carbon chain length of peroxisomal beta-oxidation in the liver of rats. Chem Biol Interact 124:119–132
Hoff PT, Scheirs J, Van de Vijver K, Van Dongen W, Esmans EL, Blust R, De Coen W (2004) Biochemical effect evaluation of perfluorooctane sulfonic acid-contaminated wood mice (Apodemus sylvaticus). Environ Health Perspect 112:681–686
Curran I, Hierlihy SL, Liston V, Pantazopoulos P, Nunnikhoven A, Tittlemier S, Barker M, Trick K, Bondy G (2008) Altered fatty acid homeostasis and related toxicologic sequelae in rats exposed to dietary potassium perfluorooctanesulfonate (PFOS). J Toxicol Environ Health A 71:1526–1541
Kudo N, Mizuguchi H, Yamamoto A, Kawashima Y (1999) Alterations by perfluorooctanoic acid of glycerolipid metabolism in rat liver. Chem Biol Interact 118:69–83
Chang SC, Noker PE, Gorman GS, Gibson SJ, Hart JA, Ehresman DJ, Butenhoff JL (2011) Comparative pharmacokinetics of perfluorooctanesulfonate (PFOS) in rats, mice, and monkeys. Reprod Toxicol. Epub ahead
Guruge KS, Yeung LW, Yamanaka N, Miyazaki S, Lam PK, Giesy JP, Jones PD, Yamashita N (2006) Gene expression profiles in rat liver treated with perfluorooctanoic acid (PFOA). Toxicol Sci 89:93–107
Martin MT, Breman R, Hu W, Ayanoglu E, Lau C, Ren H, Wood CR, Corton JC, Kavlock RJ, Dix DJ (2007) Toxicogenomic study of triazole fungicides and perfluoroalkyl acids in rat livers accurately categorizes chemicals and identifies mechanisms of toxicity. Toxicol Sci 97:595–613
Rosen MB, Thibodeaux JR, Wood CR, Zehr RD, Schmid JE, Lau C (2007) Gene expression profiling in the lung and liver of PFOA-exposed mouse fetuses. Toxicology 239:15–33
Shipley JM, Hurst CH, Tanaka SS, DeRoos FL, Butenhoff JL, Seacat AM, Waxman DJ (2004) trans-Activation of PPARα and induction of PPARα target genes by perfluorooctane-based chemicals. Toxicol Sci 80:151–160
Kato K, Wong LY, Jia LT, Kuklenyik Z, Calafat AM (2011) Trends in exposure to polyfluoroalkyl chemicals in the U.S. population: 1999–2008. Environ Sci Technol 45: 8037–8045
Wolf DC, Moore T, Abbott BD, Rosen MB, Das KP, Zehr RD, Lindstrom AB, Strynar MJ, Lau C (2008) Comparative hepatic effects of perfluorooctanoic acid and WY 14,643 in PPARα-knocked out and wild-type mice. Toxicol Pathol 36:632–639
Rosen MB, Schmid JR, Zehr RD, Das KP, Abbott BD, Lau C (2010) Gene expression profiling in wild-type and PPARα-null mice exposed to perfluorooctane sulfonate reveals PPARα-independent effects. PPAR Res. Epub ahead
Starkov AA, Wallace KB (2002) Structural determinants of fluorochemical-induced mitochondrial dysfunction. Toxicol Sci 66:244–252
Elcombe CR, Elcombe BM, Foster JR, Farrar DG, Jung R, Chang SC, Kennedy GL, Butenhoff JL (2010) Hepatocellular hypertrophy and cell proliferation in Sprague–Dawley rats following dietary exposure to ammonium perfluorooctanoate occurs through increased activation of the xenosensor nuclear receptors PPARα and CAR/PXR. Arch Toxicol 84:787–798
Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Barbee BD, Richards JH, Butenhoff JL, Stevenson LA, Lau C (2003) Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I. Maternal and prenatal evaluations. Toxicol Sci 74:369–381
Luebker DJ, Case MT, York RG, Moore JA, Hansen KJ, Butenhoff JL (2005) Two-generation reproduction and cross-foster studies of perfluorooctanesulfonate (PFOS) in rats. Toxicology 215:126–148
Lau C, Thibodeaux JR, Hanson RG, Narotsky MG, Rogers JM, Lindstrom AB, Strynar MJ (2006) Effects of perfluorooctanoic acid exposure during pregnancy in the mouse. Toxicol Sci 90:510–518
Era S, Harada KH, Toyoshima M, Inoue K, Minata M, Saito N, Takigawa T, Shiota K, Koizumi A (2009) Cleft palate caused by perfluorooctane sulfonate is caused mainly by extrinsic factors. Toxicology 256:42–47
Das KP, Grey BE, Zehr RD, Wood CR, Butenhoff JL, Chang SC, Ehresman DJ, Tan YM, Lau C (2008) Effects of perfluorobutyrate exposure during pregnancy in the mouse. Toxicol Sci 105:173–181
Harris MW, Birnbaum LS (1989) Developmental toxicity of perfluorodecanoic acid in C57BL/6N mice. Fundam Appl Toxicol 12:442–448
Lau C, Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Stanton ME, Butenhoff JL, Stevenson LA (2003) Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II. Postnatal evaluation. Toxicol Sci 74:382–392
Luebker DJ, York RG, Hansen KJ, Moore JA, Butenhoff JL (2005) Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague–Dawley rats: dose-response, and biochemical and pharmacokinetic parameters. Toxicology 215:149–169
Yu WG, Liu W, Jin YH, Liu XH, Wang FQ, Liu L, Nakayama SF (2009) Prenatal and postnatal impact of perfluorooctane sulfonate (PFOS) on rat development: a cross-foster study on chemical burden and thyroid hormone system. Environ Sci Technol 43:8416–8422
Grasty RC, Wolf DC, Grey BE, Lau CS, Rogers JM (2003) Prenatal window of susceptibility to perfluorooctane sulfonate-induced neonatal mortality in the Sprague–Dawley rat. Birth Defects Res B Dev Reprod Toxicol 68:465–471
Grasty RC, Bjork JA, Wallace KB, Wolf DC, Lau CS, Rogers JM (2005) Effects of prenatal perfluorooctane sulfonate (PFOS) exposure on lung maturation in the perinatal rat. Birth Defects Res B Dev Reprod Toxicol 74:405–416
Borg D, Bogdanska J, Sundström M, Nobel S, Håkansson H, Bergman A, Depierre JW, Halldin K, Bergström U (2010) Tissue distribution of (35)S-labelled perfluorooctane sulfonate (PFOS) in C57Bl/6 mice following late gestational exposure. Reprod Toxicol 30: 558–565
Butenhoff JL, Kennedy GL, Frame SR, O’Connor JC, York RG (2004) The reproductive toxicology of ammonium perfluorooctanoate (APFO) in the rat. Toxicology 196:95–116
Wolf CJ, Fenton SE, Schmid JE, Calafat AM, Kuklenyik Z, Bryant XA, Thibodeaux J, Das KP, White SS, Lau CS, Abbott BD (2007) Developmental toxicity of perfluorooctanoic acid in the CD-1 mouse after cross-foster and restricted gestational exposures. Toxicol Sci 95:462–473
White SS, Calafat AM, Kuklenyik Z, Villanueva L, Zehr RD, Helfant L, Strynar MJ, Lindstrom AB, Thibodeaux JR, Wood C, Fenton SE (2007) Gestational PFOA exposure of mice is associated with altered mammary gland development in dams and female offspring. Toxicol Sci 96:133–144
Hines EP, White SS, Stanko JP, Gibbs-Flournoy EA, Lau C, Fenton SE (2009) Phenotypic dichotomy following developmental exposure to perfluorooctanoic acid (PFOA) in female CD-1 mice: low doses induce elevated serum leptin and insulin, and overweight in mid-life. Mol Cell Endocrinol 304:97–105
Barker DJ (2007) Obesity and early life. Obes Rev 8(Suppl 1):45–49
White SS, Kato K, Jia LT, Basden BJ, Calafat AM, Hines EP, Stanko JP, Wolf CJ, Abbott BD, Fenton SE (2009) Effects of perfluorooctanoic acid on mouse mammary gland development and differentiation resulting from cross-foster and restricted gestational exposures. Reprod Toxicol 27:289–298
Abbott BD (2009) Review of the expression of peroxisome proliferator-activated receptors alpha (PPARα), β (PPARβ), and γ (PPARγ) in rodent and human development. Reprod Toxicol 27:246–257
Abbott BD, Wolf CJ, Schmid JE, Das K, Zehr RD, Helfant L, Nakayama S, Lindstrom AB, Strynar MJ, Lau C (2007) Perfluorooctanoic acid (PFOA)-induced developmental toxicity in the mouse is dependent on expression of peroxisome proliferator activated receptor-alpha (PPARα). Toxicol Sci 98:571–581
Abbott BD, Wolf CJ, Das KP, Zehr RD, Schmid JE, Lindstrom AB, Strynar MJ, Lau C (2009) Developmental toxicity of perfluorooctane sulfonate (PFOS) is not dependent on expression of peroxisome proliferator activated receptor-α (PPARα) in the mouse. Reprod Toxicol 27:258–265
Wolf CJ, Zehr RD, Schmid JE, Lau C, Abbott BD (2010) Developmental effects of perfluorononanoic acid in the mouse are dependent on peroxisome proliferator-activated receptor-α. PPAR Res. Epub ahead
Butenhoff JL, Chang SC, Ehresman DJ, York RG (2009) Evaluation of potential reproductive and developmental toxicity of potassium perfluorohexanesulfonate in Sprague Dawley rats. Reprod Toxicol 27:331–341
Yang Q, Xie Y, Depierre JW (2000) Effects of peroxisome proliferators on the thymus and spleen of mice. Clin Exp Immunol 122:219–226
Yang Q, Xie Y, Eriksson AM, Nelson BD, DePierre JW (2001) Further evidence for the involvement of inhibition of cell proliferation and development in thymic and splenic atrophy induced by the peroxisome proliferator perfluoroctanoic acid in mice. Biochem Pharmacol 62:1133–1140
Yang Q, Abedi-Valugerdi M, Xie Y, Zhao XY, Möller G, Nelson BD, DePierre JW (2002) Potent suppression of the adaptive immune response in mice upon dietary exposure to the potent peroxisome proliferator, perfluorooctanoic acid. Int Immunopharmacol 2:389–397
Yang Q, Xie Y, Alexson SE, Nelson BD, DePierre JW (2002) Involvement of the peroxisome proliferator-activated receptor α in the immunomodulation caused by peroxisome proliferators in mice. Biochem Pharmacol 63:1893–1900
DeWitt JC, Shnyra A, Badr MZ, Loveless SE, Hoban D, Frame SR, Cunard R, Anderson SE, Meade BJ, Peden-Adams MM, Luebke RW, Luster MI (2009) Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor α. Crit Rev Toxicol 39:76–94
Fairley KJ, Purdy R, Kearns S, Anderson SE, Meade BJ (2007) Exposure to the immunosuppressant, perfluorooctanoic acid, enhances the murine IgE and airway hyperreactivity response to ovalbumin. Toxicol Sci 97:375–383
Son HY, Lee S, Tak EN, Cho HS, Shin HI, Kim SH, Yang JH (2009) Perfluorooctanoic acid alters T lymphocyte phenotypes and cytokine expression in mice. Environ Toxicol 24: 580–588
Dewitt JC, Copeland CB, Strynar MJ, Luebke RW (2008) Perfluorooctanoic acid-induced immunomodulation in adult C57BL/6J or C57BL/6N female mice. Environ Health Perspect 116:644–650
Loveless SE, Hoban D, Sykes G, Frame SR, Everds NE (2008) Evaluation of the immune system in rats and mice administered linear ammonium perfluorooctanoate. Toxicol Sci 105:86–96
DeWitt JC, Copeland CB, Luebke RW (2009) Suppression of humoral immunity by perfluorooctanoic acid is independent of elevated serum corticosterone concentration in mice. Toxicol Sci 109:106–112
Fang X, Zhang L, Feng Y, Zhao Y, Dai J (2008) Immunotoxic effects of perfluorononanoic acid on BALB/c mice. Toxicol Sci 105:312–321
Fang X, Feng Y, Shi Z, Dai J (2009) Alterations of cytokines and MAPK signaling pathways are related to the immunotoxic effect of perfluorononanoic acid. Toxicol Sci 108:367–376
Fang X, Feng Y, Wang J, Dai J (2010) Perfluorononanoic acid-induced apoptosis in rat spleen involves oxidative stress and the activation of caspase-independent death pathway. Toxicology 267:54–59
Peden-Adams MM, EuDaly JG, Dabra S, EuDaly A, Heesemann L, Smythe J, Keil DE (2007) Suppression of humoral immunity following exposure to the perfluorinated insecticide sulfluramid. J Toxicol Environ Health A 70:1130–1141
Qazi MR, Xia Z, Bogdanska J, Chang SC, Ehresman DJ, Butenhoff JL, Nelson BD, DePierre JW, Abedi-Valugerdi M (2009) The atrophy and changes in the cellular compositions of the thymus and spleen observed in mice subjected to short-term exposure to perfluorooctanesulfonate are high-dose phenomena mediated in part by peroxisome proliferator-activated receptor-α (PPARα). Toxicology 260:68–76
Lefebvre DE, Curran I, Armstrong C, Coady L, Parenteau M, Liston V, Barker M, Aziz S, Rutherford K, Bellon-Gagnon P, Shenton J, Mehta R, Bondy G (2008) Immunomodulatory effects of dietary potassium perfluorooctane sulfonate (PFOS) exposure in adult Sprague–Dawley rats. J Toxicol Environ Health A 71:1516–1525
Peden-Adams MM, Keller JM, Eudaly JG, Berger J, Gilkeson GS, Keil DE (2008) Suppression of humoral immunity in mice following exposure to perfluorooctane sulfonate. Toxicol Sci 104:144–154
Zheng L, Dong GH, Jin YH, He QC (2009) Immunotoxic changes associated with a 7-day oral exposure to perfluorooctanesulfonate (PFOS) in adult male C57BL/6 mice. Arch Toxicol 83:679–689
Dong GH, Zhang YH, Zheng L, Liu W, Jin YH, He QC (2009) Chronic effects of perfluorooctanesulfonate exposure on immunotoxicity in adult male C57BL/6 mice. Arch Toxicol 83:805–815
Dong, G.-H., Zhang, Y.-H., Zheng, L., Liang, Z.-F., Jin, Y.-H, and He, Q.-C. (2012), Subchronic effects of perfluorooctanesulfonate exposure on inflammation in adult male C57BL/6 mice. Environ Toxicol 27:285–296
Qazi MR, Nelson BD, Depierre JW, Abedi-Valugerdi M (2010) 28-Day dietary exposure of mice to a low total dose (7 mg/kg) of perfluorooctanesulfonate (PFOS) alters neither the cellular compositions of the thymus and spleen nor humoral immune responses: does the route of administration play a pivotal role in PFOS-induced immunotoxicity? Toxicology 267:132–139
Keil DE, Mehlmann T, Butterworth L, Peden-Adams MM (2008) Gestational exposure to perfluorooctane sulfonate suppresses immune function in B6C3F1 mice. Toxicol Sci 103: 77–85
Guruge KS, Hikono H, Shimada N, Murakami K, Hasegawa J, Yeung LW, Yamanaka N, Yamashita N (2009) Effect of perfluorooctane sulfonate (PFOS) on influenza A virus-induced mortality in female B6C3F1 mice. J Toxicol Sci 34:687–691
Qazi MR, Bogdanska J, Butenhoff JL, Nelson BD, DePierre JW, Abedi-Valugerdi M (2009) High-dose, short-term exposure of mice to perfluorooctanesulfonate (PFOS) or perfluorooctanoate (PFOA) affects the number of circulating neutrophils differently, but enhances the inflammatory responses of macrophages to lipopolysaccharide (LPS) in a similar fashion. Toxicology 262:207–214
Qazi MR, Abedi MR, Nelson BD, DePierre JW, Abedi-Valugerdi M (2010) Dietary exposure to perfluorooctanoate or perfluorooctane sulfonate induces hypertrophy in centrilobular hepatocytes and alters the hepatic immune status in mice. Int Immunopharmacol 10: 1420–1427
Jensen AA, Leffers H (2008) Emerging endocrine disrupters: perfluoroalkylated substances. Int J Androl 31:161–169
Langley AE, Pilcher GD (1985) Thyroid, bradycardic and hypothermic effects of perfluoro-n-decanoic acid in rats. J Toxicol Environ Health 15:485–491
Gutshall DM, Pilcher GD, Langley AE (1989) Mechanism of the serum thyroid hormone lowering effect of perfluoro-n-decanoic acid (PFDA) in rats. J Toxicol Environ Health 28: 53–65
Seacat AM, Thomford PJ, Hansen KJ, Olsen GW, Case MT, Butenhoff JL (2002) Subchronic toxicity studies on perfluorooctanesulfonate potassium salt in Cynomolgus monkeys. Toxicol Sci 68:249–264
Yu WG, Liu W, Jin YH (2009) Effects of perfluorooctane sulfonate on rat thyroid hormone biosynthesis and metabolism. Environ Toxicol Chem 28:990–996
Chang SC, Ehresman DJ, Bjork JA, Wallace KB, Parker GA, Stump DG, Butenhoff JL (2009) Gestational and lactational exposure to potassium perfluorooctanesulfonate (K+PFOS) in rat: toxicokinetics, thyroid hormone status, and related gene expression. Reprod Toxicol 27:387–399
Chang S, Thibodeaux JR, Eastvold ML, Ehresman DJ, Bjork J, Froehlich JW, Lau C, Singh RJ, Wallace KB, Butenhoff JL (2007) Negative bias from analog methods used in the analysis of free thyroid hormones in rat serum containing perfluorooctanesulfonate (PFOS). Toxicology 234:21–33
Chang S, Thibodeaux JR, Eastvold ML, Ehresman DJ, Bjork JA, Froehlich JW, Lau C, Singh RJ, Wallace KB, Butenhoff JL (2008) Thyroid hormone status and pituitary function in adult rats given oral doses of perfluorooctanesulfonate (PFOS). Toxicology 243:330–339
Weiss JM, Andersson PL, Lamoree MH, Leonards PEG, van Leeuwen SPJ, Hamers T (2009) Competitive binding of poly- and perfluorinated compounds to the thyroid hormone transport protein transthyretin. Toxicol Sci 109:206–216
Bjork JA, Lau C, Chang S, Butenhoff JL, Wallace KB (2008) Perfluorooctane sulfonate-induced changes in neonatal rat liver gene expression. Toxicology 251:8–20
Cook JC, Murray SM, Frame SR, Hurtt ME (1992) Induction of Leydig cell adenomas by ammonium perfluorooctanoate: a possible endocrine-related mechanism. Toxicol Appl Pharmacol 113:209–217
Liu C, Du Y, Zhou B (2007) Evaluation of estrogenic activities and mechanism of action of perfluorinated chemicals determined by vitellogenin induction in primary cultured tilapia hepatocytes. Aquat Toxicol 85:267–277
Ishibashi H, Ishida H, Matsuoka M, Tominaga N, Arizono K (2007) Estrogenic effects of fluorotelomer alcohols for human estrogen receptor isoforms α and β in vitro. Biol Pharm Bull 30:1358–1359
Ishibashi H, Yamauchi R, Matsuoka M, Kim JW, Hirano M, Yamaguchi A, Tominaga N, Arizono K (2008) Fluorotelomer alcohols induce hepatic vitellogenin through activation of the estrogen receptor in male medaka (Oryzias latipes). Chemosphere 71:1853–1859
Zhao B, Chu Y, Hardy DO, Li XK, Ge RS (2010) Inhibition of 3β- and 17β-hydroxysteroid dehydrogenase activities in rat Leydig cells by perfluorooctane acid. J Steroid Biochem Mol Biol 118:13–17
Liao C, Wang T, Cui L, Zhou Q, Duan S, Jiang G (2009) Changes in synaptic transmission, calcium current, and neurite growth by perfluorinated compounds are dependent on the chain length and functional group. Environ Sci Technol 43:2099–2104
Shi Z, Zhang H, Liu Y, Xu M, Dai J (2007) Alterations in gene expression and testosterone synthesis in the testes of male rats exposed to perfluorododecanoic acid. Toxicol Sci 98: 206–215
Shi Z, Ding L, Zhang H, Feng Y, Xu M, Dai J (2009) Chronic exposure to perfluorododecanoic acid disrupts testicular steroidogenesis and the expression of related genes in male rats. Toxicol Lett 188:192–200
Shi Z, Zhang H, Ding L, Feng Y, Xu M, Dai J (2009) The effect of perfluorododecanonic acid on endocrine status, sex hormones and expression of steroidogenic genes in pubertal female rats. Reprod Toxicol 27:352–359
Shi Z, Zhang H, Ding L, Feng Y, Wang J, Dai J (2010) Proteomic analysis for testis of rats chronically exposed to perfluorododecanoic acid. Toxicol Lett 192:179–188
Shi Z, Feng Y, Wang J, Zhang H, Ding L, Dai J (2010) Perfluorododecanoic acid-induced steroidogenic inhibition is associated with steroidogenic acute regulatory protein and reactive oxygen species in cAMP-stimulated Leydig cells. Toxicol Sci 114:285–294
Slotkin TA, MacKillop EA, Melnick RL, Thayer KA, Seidler FJ (2008) Developmental neurotoxicity of perfluorinated chemicals modeled in vitro. Environ Health Perspect 116: 716–722
Liao CY, Li XY, Wu B, Duan S, Jiang GB (2008) Acute enhancement of synaptic transmission and chronic inhibition of synaptogenesis induced by perfluorooctane sulfonate through mediation of voltage-dependent calcium channel. Environ Sci Technol 42:5335–5341
Fuentes S, Vicens P, Colomina MT, Domingo JL (2007) Behavioral effects in adult mice exposed to perfluorooctane sulfonate (PFOS). Toxicology 242:123–129
Liu X, Liu W, Jin Y, Yu W, Liu L, Yu H (2010) Effects of subchronic perfluorooctane sulfonate exposure of rats on calcium-dependent signaling molecules in the brain tissue. Arch Toxicol 84:471–479
Sato I, Kawamoto K, Nishikawa Y, Tsuda S, Yoshida M, Yaegashi K, Saito N, Liu W, Jin Y (2009) Neurotoxicity of perfluorooctane sulfonate (PFOS) in rats and mice after single oral exposure. J Toxicol Sci 34:569–574
Butenhoff JL, Ehresman DJ, Chang SC, Parker GA, Stump DG (2009) Gestational and lactational exposure to potassium perfluorooctanesulfonate (K+PFOS) in rats: developmental neurotoxicity. Reprod Toxicol 27:319–330
Liu X, Liu W, Jin Y, Yu W, Wang F, Liu L (2010) Effect of gestational and lactational exposure to perfluorooctanesulfonate on calcium-dependent signaling molecules gene expression in rats’ hippocampus. Arch Toxicol 84:71–79
Wang F, Liu W, Jin Y, Dai J, Yu W, Liu X, Liu L (2010) Transcriptional effects of prenatal and neonatal exposure to PFOS in developing rat brain. Environ Sci Technol 44:1847–1853
Johansson N, Fredriksson A, Eriksson P (2008) Neonatal exposure to perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) causes neurobehavioural defects in adult mice. Neurotoxicology 29:160–169
Johansson N, Eriksson P, Viberg H (2009) Neonatal exposure to PFOS and PFOA in mice results in changes in proteins which are important for neuronal growth and synaptogenesis in the developing brain. Toxicol Sci 108:412–418
Pinkas A, Slotkin TA, Brick-Turin Y, Van der Zee EA, Yanai J (2010) Neurobehavioral teratogenicity of perfluorinated alkyls in an avian model. Neurotoxicol Teratol 32:182–186
Wolf CJ, Takacs MR, Schmid JE, Lau C, Abbott BD (2008) Differential activation of mouse and human peroxisome proliferator-activated receptor-α (PPARα) by perfluoroalkyl carboxylates and sulfonates of different chain lengths. Toxicol Sci 106:162–171
Klaunig JE, Babich MA, Baetcke KP, Cook JC, Corton JC, David RM, DeLuca JG, Lai DY, McKee RH, Peters JM, Roberts RA, Fenner-Crisp PA (2003) PPARα agonist-induced rodent tumors: modes of action and human relevance. Crit Rev Toxicol 33:655–780
Cohen SM, Meek ME, Klaunig JE, Patton DE, Fenner-Crisp PA (2003) The human relevance of information on carcinogenic modes of action: overview. Crit Rev Toxicol 33:581–589
Nakamura T, Ito Y, Yanagiba Y, Ramdhan DH, Kono Y, Naito H, Hayashi Y, Li Y, Aoyama T, Gonzalez FJ, Nakajima T (2009) Microgram-order ammonium perfluorooctanoate may activate mouse peroxisome proliferator-activated receptor alpha, but not human PPARα. Toxicology 265:27–33
Guyton KZ, Chiu WA, Bateson TF, Jinot J, Scott CS, Brown RC, Caldwell JC (2009) A reexamination of the PPAR-α activation mode of action as a basis for assessing human cancer risks of environmental contaminants. Environ Health Perspect 117:1664–1672
Zhang H, Shi Z, Liu Y, Wei Y, Dai J (2008) Lipid homeostasis and oxidative stress in the liver of male rats exposed to perfluorododecanoic acid. Toxicol Appl Pharmacol 227:16–25
Qian Y, Ducatman A, Ward R, Leonard S, Bukowski V, Lan Guo N, Shi X, Vallyathan V, Castranova V (2010) Perfluorooctane sulfonate (PFOS) induces reactive oxygen species (ROS) production in human microvascular endothelial cells: role in endothelial permeability. J Toxicol Environ Health A 73:819–836
Xie W, Wu Q, Kania-Korwel I, Tharappel JC, Telu S, Coleman MC, Glauert HP, Kannan K, Mariappan SV, Spitz DR, Weydert J, Lehmler HJ (2009) Subacute exposure to N-ethyl perfluorooctanesulfonamidoethanol results in the formation of perfluorooctanesulfonate and alters superoxide dismutase activity in female rats. Arch Toxicol 83:909–924
Liu C, Zhang X, Chang H, Jones P, Wiseman S, Naile J, Hecker M, Giesy JP, Zhou B (2010) Effects of fluorotelomer alcohol 8:2 FTOH on steroidogenesis in H295R cells: targeting the cAMP signalling cascade. Toxicol Appl Pharmacol 247:222–228
Feng Y, Shi Z, Fang X, Xu M, Dai J (2009) Perfluorononanoic acid induces apoptosis involving the Fas death receptor signaling pathway in rat testis. Toxicol Lett 190:224–230
Guerrero-Preston R, Goldman LR, Brebi-Mieville P, Ili-Gangas C, Lebron C, Hernández-Arroyo M, Witter FR, Apelberg BJ, Roystacher M, Jaffe A, Halden RU, Sidransky D (2010) Global DNA hypomethylation is associated with in utero exposure to cotinine and perfluorinated alkyl compounds. Epigenetics 5:539–546
Alexander BH, Olsen GW, Burris JM, Mandel JH, Mandel JS (2003) Mortality of employees of a perfluorooctanesulphonyl fluoride manufacturing facility. Occup Environ Med 60:722–729
Alexander BH, Olsen GW (2007) Bladder cancer in perfluorooctanesulfonyl fluoride manufacturing workers. Ann Epidemiol 17:471–478
Grice MM, Alexander BH, Hoffbeck R, Kampa DM (2007) Self-reported medical conditions in perfluorooctanesulfonyl fluoride manufacturing workers. J Occup Environ Med 49:722–729
Olsen GW, Burlew MM, Marshall JC, Burris JM, Mandel JH (2004) Analysis of episodes of care in a perfluorooctanesulfonyl fluoride production facility. J Occup Environ Med 46:837–846
Olsen GW, Zobel LR (2007) Assessment of lipid, hepatic, and thyroid parameters with serum perfluorooctanoate (PFOA) concentrations in fluorochemical production workers. Int Arch Occup Environ Health 81:231–246
Lundin JI, Alexander BH, Olsen GW, Church TR (2009) Ammonium perfluorooctanoate production and occupational mortality. Epidemiology 20:921–928
Costa G, Sartori S, Consonni D (2009) Thirty years of medical surveillance in perfluooctanoic acid production workers. J Occup Environ Med 51:364–372
Butenhoff JL, Gaylor DW, Moore JA, Olsen GW, Rodricks J, Mandel JH, Zobel LR (2004) Characterization of risk for general population exposure to perfluorooctanoate. Regul Toxicol Pharmacol 39:363–380
Mundt DJ, Mundt KA, Luippold RS, Schmidt MD, Farr CH (2007) Clinical epidemiological study of employees exposed to surfactant blend containing perfluorononanoic acid. Occup Environ Med 64:589–594
Fei C, McLaughlin JK, Lipworth L, Olsen J (2009) Maternal levels of perfluorinated chemicals and subfecundity. Hum Reprod 24:1200–1205
Fei C, McLaughlin JK, Tarone RE, Olsen J (2008) Fetal growth indicators and perfluorinated chemicals: a study in the Danish National Birth Cohort. Am J Epidemiol 168:66–72
Washino N, Saijo Y, Sasaki S, Kato S, Ban S, Konishi K, Ito R, Nakata A, Iwasaki Y, Saito K, Nakazawa H, Kishi R (2009) Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growth. Environ Health Perspect 117:660–667
Monroy R, Morrison K, Teo K, Atkinson S, Kubwabo C, Stewart B, Foster WG (2008) Serum levels of perfluoroalkyl compounds in human maternal and umbilical cord blood samples. Environ Res 108:56–62
Nolan LA, Nolan JM, Shofer FS, Rodway NV, Emmett EA (2009) The relationship between birth weight, gestational age and perfluorooctanoic acid (PFOA)-contaminated public drinking water. Reprod Toxicol 27:231–238
Hamm MP, Cherry NM, Chan E, Martin JW, Burstyn I (2010) Maternal exposure to perfluorinated acids and fetal growth. J Exp Sci Environ Epidemiol 20:589–597
Stein CR, Savitz DA, Dougan M (2009) Serum levels of perfluorooctanoic acid and perfluorooctane sulfonate and pregnancy outcome. Am J Epidemiol 170:837–846
Nolan LA, Nolan JM, Shofer FS, Rodway NV, Emmett EA (2010) Congenital anomalies, labor/delivery complications, maternal risk factors and their relationship with perfluorooctanoic acid (PFOA)-contaminated public drinking water. Reprod Toxicol 29:147–155
Fei C, McLaughlin JK, Lipworth L, Olsen J (2010) Prenatal exposure to PFOA and PFOS and risk of hospitalization for infectious diseases in early childhood. Environ Res 110:773–777
Fei C, McLaughlin JK, Lipworth L, Olsen J (2008) Prenatal exposure to perfluorooctanoate (PFOA) and perfluorooctanesulfonate (PFOS) and maternally reported developmental milestones in infancy. Environ Health Perspect 116:1391–1395
Fei C, Olsen J (2011) Prenatal exposure to perfluorinated chemicals and behavioral or coordination problems at age 7 years. Environ Health Perspect 119:573–578
Christensen KY, Maisonet M, Rubin C, Holmes A, Calafat AM, Kato K, Flanders WD, Heron J, McGeehin MA, Marcus M (2011) Exposure to polyfluoroalkyl chemicals during pregnancy is not associated with offspring age at menarche in a contemporary British cohort. Environ Int 37:129–135
Steenland K, Tinker S, Frisbee S, Ducatman A, Vaccarino V (2009) Association of perfluorooctanoic acid and perfluorooctane sulfonate with serum lipids among adults living near a chemical plant. Am J Epidemiol 170:1268–1278
Frisbee SJ, Shankar A, Knox SS, Steenland K, Savitz DA, Fletcher T, Ducatman AM (2010) Perfluorooctanoic acid, perfluorooctanesulfonate, and serum lipids in children and adolescents: results from the C8 Health Project. Arch Pediatr Adolesc Med 164:860–869
MacNeil J, Steenland NK, Shankar A, Ducatman A (2009) A cross-sectional analysis of type II diabetes in a community with exposure to perfluorooctanoic acid (PFOA). Environ Res 109:997–1003
Steenland K, Tinker S, Shankar A, Ducatman A (2010) Association of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) with uric acid among adults with elevated community exposure to PFOA. Environ Health Perspect 118:229–233
Lin CY, Chen PC, Lin YC, Lin LY (2009) Association among serum perfluoroalkyl chemicals, glucose homeostasis, and metabolic syndrome in adolescents and adults. Diabetes Care 32:702–707
Lin CY, Lin LY, Chiang CK, Wang WJ, Su YN, Hung KY, Chen PC (2009) Investigation of the associations between low-dose serum perfluorinated chemicals and liver enzymes in US adults. Am J Gastroenterol 105:1354–1363
Nelson JW, Hatch EE, Webster TF (2010) Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general U.S. population. Environ Health Perspect 118:197–202
Melzer D, Rice N, Depledge MH, Henley WE, Galloway TS (2010) Association between serum perfluorooctanoic acid (PFOA) and thyroid disease in the U.S. National Health and Nutrition Examination Survey. Environ Health Perspect 118:686–692
Hoffman K, Webster TF, Weisskopf MG, Weinberg J, Vieira VM (2010) Exposure to polyfluoroalkyl chemicals and attention deficit hyperactivity disorder in U.S. children aged 12-15 years. Environ Health Perspect 118:1762–1767
Joensen UN, Bossi R, Leffers H, Jensen AA, Skakkebaek NE, Jørgensen N (2009) Do perfluoroalkyl compounds impair human semen quality? Environ Health Perspect 117:923–927
Eriksen KT, Sørensen M, McLaughlin JK, Lipworth L, Tjønneland A, Overvad K, Raaschou-Nielsen O (2009) Perfluorooctanoate and perfluorooctanesulfonate plasma levels and risk of cancer in the general Danish population. J Natl Cancer Inst 101:605–609
Zhao B, Hu GX, Chu Y, Jin X, Gong S, Akingbemi BT, Zhang Z, Zirkin BR, Ge RS (2010) Inhibition of human and rat 3β -hydroxysteroid dehydrogenase and 17β-hydroxysteroid dehydrogenase 3 activities by perfluoroalkylated substances. Chem Biol Interact 188: 38–43
Acknowledgments
The information in this document has been subjected to review by the Office of Pollution Prevention and Toxics and the Office of Research and Development of US Environmental Protection Agency and approved for publication. Approval does not signify that the contents reflect the views of the agency, nor does mention of trade names or commercial products constitute endorsement or recommendation for use.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Basel AG
About this chapter
Cite this chapter
Lau, C. (2012). Perfluorinated Compounds. In: Luch, A. (eds) Molecular, Clinical and Environmental Toxicology. Experientia Supplementum, vol 101. Springer, Basel. https://doi.org/10.1007/978-3-7643-8340-4_3
Download citation
DOI: https://doi.org/10.1007/978-3-7643-8340-4_3
Published:
Publisher Name: Springer, Basel
Print ISBN: 978-3-7643-8339-8
Online ISBN: 978-3-7643-8340-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)